ASTELLAS PHARMA, INC. (ALPMF)
Clinical trial NCT05756777 updates: 1. start date: 2023-06-26 → 2023-10-25 2. completion date: 2027-02-01 → 2027-04-21 3. primary completion date: 2027-02-01 → 2027-04-21
Clinical trial NCT05756777 updates: 1. start date: 2023-06-26 → 2023-10-25 2. completion date: 2027-02-01 → 2027-04-21 3. primary completion date: 2027-02-01 → 2027-04-21
Clinical trial NCT06723795: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT06079879: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT06997276 updates: 1. completion date: 2026-09-01 → 2026-09-30 2. primary completion date: 2026-09-01 → 2026-09-30
Clinical trial NCT06824207 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-30 → 2026-05-19 3. primary completion date: 2026-05-30 → 2026-05-19 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07635147: status: NOT_YET_RECRUITING → RECRUITING.
Clinical trial NCT07047716 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 350 → 339 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06741228: primary completion date: 2026-05-01 → 2026-07-01.
Clinical trial NCT07193199: primary completion date: 2026-05-24 → 2026-06-01.
Clinical trial NCT07540143 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-15 → 2026-06-16